Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT06212674
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 240 participants
- Sponsor
- Registry
-
NCT06212674
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT06212674. Randomized; no masking; primary purpose other. Start 2025-10-31 (actual); primary completion 2027-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
- Acronym
- PILOS-AF
- Condition
- Ischemic Stroke
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- PVI + LAAO, single stage
- Intervention (Procedure)
- LAAO
- Intervention (Drug)
- NOAC
- Lead sponsor
- Medical University of Silesia
- Collaborator
- Medical University of Lodz
- Collaborator
- Silesian Centre for Heart Diseases
- Collaborator
- Pomeranian Medical University Szczecin
- Collaborator
- American Heart of Poland
- Collaborator
- Leszek Giec Upper-Silesian Medical Centre
Record details
- Record id
cardio:ct-nct06212674- Content hash
f5f0adc15bc0587629ee29c7150f0d63694103a29a07c3a2ee75653a4fab48ee